Financials Jiangsu Apon Medical Technology Co., Ltd.

Equities

300753

CNE100003FV4

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
11.8 CNY +1.29% Intraday chart for Jiangsu Apon Medical Technology Co., Ltd. +11.85% -31.28%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,242 3,293 2,658 2,558 2,278 2,164
Enterprise Value (EV) 1 2,806 2,873 2,269 2,323 2,097 2,038
P/E ratio 34.6 x 32.2 x 27.4 x 47.3 x -29.8 x 261 x
Yield 1% 0.98% 1.19% - - -
Capitalization / Revenue 10.9 x 8.67 x 6 x 5.55 x 7.03 x 5.13 x
EV / Revenue 9.41 x 7.57 x 5.12 x 5.04 x 6.48 x 4.83 x
EV / EBITDA 31.5 x 29.3 x 21.4 x 38.4 x -31 x 54.9 x
EV / FCF 11,226 x -139 x 93.7 x -39.4 x -101 x -31.6 x
FCF Yield 0.01% -0.72% 1.07% -2.54% -0.99% -3.16%
Price to Book 5.36 x 4.88 x 3.59 x 3.28 x 3.32 x 3.1 x
Nbr of stocks (in thousands) 126,049 126,049 126,049 126,048 126,048 126,048
Reference price 2 25.72 26.13 21.08 20.29 18.07 17.17
Announcement Date 3/15/19 4/23/20 4/23/21 2/25/22 4/23/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 298 379.6 443.1 461.2 323.8 422.2
EBITDA 1 88.96 98.18 106.1 60.55 -67.56 37.09
EBIT 1 80.07 88.81 96.49 48.12 -80.72 24.42
Operating Margin 26.87% 23.39% 21.78% 10.43% -24.93% 5.78%
Earnings before Tax (EBT) 1 83.74 117.8 111.9 55.3 -90.71 13.81
Net income 1 70.09 102.3 96.96 54.06 -76.38 8.277
Net margin 23.52% 26.96% 21.88% 11.72% -23.59% 1.96%
EPS 2 0.7436 0.8119 0.7693 0.4289 -0.6059 0.0657
Free Cash Flow 1 0.2499 -20.61 24.22 -59 -20.74 -64.48
FCF margin 0.08% -5.43% 5.47% -12.79% -6.41% -15.27%
FCF Conversion (EBITDA) 0.28% - 22.83% - - -
FCF Conversion (Net income) 0.36% - 24.98% - - -
Dividend per Share 2 0.2564 0.2564 0.2500 - - -
Announcement Date 3/15/19 4/23/20 4/23/21 2/25/22 4/23/23 4/25/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 436 421 389 235 181 126
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.25 -20.6 24.2 -59 -20.7 -64.5
ROE (net income / shareholders' equity) 15.9% 16% 13.7% 7.01% -10.4% 1.22%
ROA (Net income/ Total Assets) 9.8% 7.68% 7.61% 3.48% -5.7% 1.76%
Assets 1 715.1 1,333 1,274 1,552 1,339 469.1
Book Value Per Share 2 4.800 5.350 5.870 6.190 5.440 5.540
Cash Flow per Share 2 3.460 3.340 3.080 2.180 1.980 1.600
Capex 1 61.6 58.3 35.6 39.6 24.2 30.7
Capex / Sales 20.66% 15.36% 8.04% 8.59% 7.46% 7.28%
Announcement Date 3/15/19 4/23/20 4/23/21 2/25/22 4/23/23 4/25/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 300753 Stock
  4. Financials Jiangsu Apon Medical Technology Co., Ltd.